Measuring HIV Self-Management in Women Living With HIV/AIDS

2012 ◽  
Vol 61 (1) ◽  
pp. e12
Author(s):  
&NA;
2012 ◽  
Vol 60 (3) ◽  
pp. e72-e81 ◽  
Author(s):  
Allison R. Webel ◽  
Alice Asher ◽  
Yvette Cuca ◽  
Jennifer G. Okonsky ◽  
Alphoncina Kaihura ◽  
...  

Author(s):  
Benissa E. Salem ◽  
Yvita Bustos ◽  
Chidyaonga Shalita ◽  
Jordan Kwon ◽  
Padma Ramakrishnan ◽  
...  

Rural women living with HIV/AIDS (WLHA) in India experience challenges self-managing HIV/AIDS in their rural communities. The purpose of this qualitative study was to explore factors influencing their care and antiretroviral treatment (ART) adherence. Themes that emerged from the qualitative focus groups among WLHA (N = 24) in rural Prakasam, Andhra Pradesh, India, included: (1) coming to know about HIV and other health conditions, (2) experiences being on ART, (3) challenges maintaining a nutritious diet, (4) factors affecting health care access and quality, and (5) seeking support for a better future. Chronic disease self-management in rural locales is challenging, given the number of barriers which rural women experience on a daily basis. These findings suggest a need for individual- and structural-level supports that will aid in assisting rural WLHA to self-manage HIV/AIDS as a chronic illness.


2018 ◽  
Author(s):  
Sylvie Naar ◽  
Jeffrey T Parsons ◽  
Bonita F Stanton

BACKGROUND The past 30 years have witnessed such significant progress in the prevention and treatment of HIV/AIDS that an AIDS-free generation and the end to the global AIDS epidemic are ambitious, but achievable, national and global goals. Despite growing optimism, globally, youth living with HIV are markedly less likely to receive antiretroviral therapy than adults (23% vs 38%). Furthermore, marked health disparities exist regarding HIV infection risk, with young men of color who have sex with men disproportionately affected. A large body of research has identified highly impactful facilitators of and barriers to behavior change. Several efficacious interventions have been created that decrease the rate of new HIV infections among youth and reduce morbidity among youth living with HIV. However, full benefits that should be possible based on the tools and interventions currently available are yet to be realized in youth, in large part, because efficacious interventions have not been implemented in real-world settings. Scale It Up (SIU) primarily aims to assemble research teams that will ultimately bring to practice evidence-based interventions that positively impact the youth HIV prevention and care cascades, and in turn, advance the fields of implementation science and self-management science. OBJECTIVE This paper aims to describe the structure of the U19-SIU and the effectiveness-implementation hybrid trials, as well as other center-wide protocols and initiatives, implemented within SIU. METHODS SIU will achieve its aims through 4 individual primary protocols, 2 center-wide protocols, and 3 cross-project initiatives. RESULTS SIU was funded by National Institute for Child Health and Human Development (U19HD089875) and began in October 2016. As of November 2018, 6 SIU protocols have launched at least the first phase of work (ATN 144 SMART: Sequential Multiple Assignment Randomized Trial; ATN 145 YMHP: Young Men’s Health Project; ATN 146 TMI: Tailored Motivational Interviewing Intervention; ATN 153 EPIS: Exploration, Preparation, Implementation, Sustainment model; ATN 154 CM: Cascade Monitoring; ATN 156 We Test: Couples' Communication and HIV Testing). Further details can be found in the individual protocol papers. CONCLUSIONS To date, the youth HIV research portfolio has not adequately advanced the important care area of self-management. SIU protocols and initiatives address this broad issue by focusing on evaluating the effectiveness and implementation of self-management interventions. SIU is highly innovative for 5 primary reasons: (1) our research framework expands the application of “self-management”; (2) the 4 primary protocols utilize innovative hybrid designs; (3) our Analytic Core will conduct cost-effectiveness analyses of each intervention; (4) across all 4 primary protocols, our Implementation Science Core will apply implementation scales designed to assess inner and outer context factors; and (5) we shall advance understanding of the dynamics between provider and patient through analysis of recorded interactions. INTERNATIONAL REGISTERED REPOR DERR1-10.2196/11204


2016 ◽  
Vol 49 (5) ◽  
pp. 421 ◽  
Author(s):  
Thiago Cândido Alves ◽  
Camila De Moraes ◽  
André Pereira dos Santos ◽  
Ana Cláudia Rossini Venturini ◽  
Rodrigo De Carvalho Santana ◽  
...  

Modelo do estudo: Estudo de prevalência de corte transversal. Objetivo: comparar a sintomatologia critério para Síndrome Metabólica em homens e mulheres que vivem com HIV/aids, pacientes com Síndrome Lipoditrófica em terapia antirretroviral. Método: participaram do estudo 41 pacientes HIV positivos de ambos os sexos (18 a 69 anos), de um programa de orientação de exercício físico como terapia alternativa. Foi determinada a composição corporal total e regional por DXA, estatura, peso, circunferência de abdome, e determinação de parâmetros metabólicos (perfil lipídico e glicêmico) e imunológicos (detecção de carga viral e contagem de células T CD4+). Foram utilizados os critérios da IDF para o diagnóstico de SM. Resultados: As mulheres apresentaram maior gordura relativa (p = 0,001), obesidade central (p = 0,005), colesterol total (p = 0,043), LDL colesterol (p = 0,034) e contagem de CD4+ (p = 0,034) quando comparadas aos homens. Os valores médios para ambos os sexos apresentaram níveis elevados de triglicerídeos (> 211,4 mg.dL-1) e baixos de HDL (< 39,5 mg.dL- 1). A prevalência de Síndrome Metabólica nas mulheres foi duas vezes maior do que nos homens (p = 0,021), com significantes diferenças também na obesidade abdominal central (p = 0,005). Conclusões: A razão de prevalência (RP = 0,465) do sexo associado à Síndrome Metabólica indicou que as mulheres têm maior risco relativo e, portanto requerem ações alternativas na redução das chances de desenvolvimento desta síndrome


Sign in / Sign up

Export Citation Format

Share Document